acut
bronchiti
inflamm
larg
airway
character
cough
andor
sputum
usual
last
one
three
week
one
common
ill
among
outpati
mani
patient
receiv
antibiot
therapi
tradit
virus
consid
main
caus
agent
acut
bronchiti
possibl
explain
limit
benefit
antibiot
howev
data
regard
caus
microorgan
still
limit
previou
studi
virus
isol
communitybas
case
frequent
enough
conclud
virus
main
causal
agent
acut
bronchiti
macfarlan
et
al
identifi
virus
patient
typic
atyp
bacteria
identifi
patient
respect
studi
bacteria
detect
sputum
sampl
acut
bronchiti
patient
addit
sever
author
suggest
patient
acut
bronchiti
mix
infect
involv
virus
bacteria
howev
exact
preval
clinic
characterist
mix
infect
well
studi
moreov
clear
subgroup
patient
acut
bronchiti
could
benefit
antibiot
treatment
recent
big
data
uk
show
antibiot
substanti
reduc
risk
pneumonia
acut
bronchiti
particularli
elderli
peopl
risk
highest
therefor
present
studi
aim
investig
frequenc
characterist
viral
bacteri
mix
infect
acut
bronchiti
commun
also
hypothes
frequenc
etiolog
would
vari
underli
lung
comorbid
age
adult
patient
acut
bronchiti
prospect
recruit
korean
hospit
outpati
depart
primari
clinic
juli
june
universityaffili
teach
hospit
nonteach
commun
hospit
primari
clinic
sputum
sampl
gram
stain
convent
cultur
polymeras
chain
reaction
pcr
collect
patient
medic
includ
antibiot
prescrib
medic
chosen
physician
discret
studi
protocol
approv
institut
review
board
hallym
univers
sacr
heart
hospit
princip
institut
particip
hospit
particip
provid
inform
written
consent
patient
elig
year
old
visit
outpati
clinic
cough
durat
month
sputum
product
acut
bronchiti
clinic
diagnosi
therefor
wrong
diagnosi
possibl
cough
symptom
may
almost
respiratori
ill
differenti
diagnosi
howev
symptom
sputum
product
care
discrimin
postnas
drip
could
also
lead
diagnosi
lower
respiratori
inflamm
patient
typic
upper
respiratori
infect
uri
symptom
influenza
influenzalik
ill
ili
epidem
period
exclud
particip
physician
tri
rule
uri
conduct
detail
medic
interview
throat
examin
auscult
typic
uri
defin
infect
affect
patient
present
key
symptom
sore
throat
nasal
symptom
nasal
obstruct
runni
nose
cough
ili
defin
abrupt
onset
fever
nonproduct
cough
sore
throat
period
influenza
epidem
determin
mean
nation
respiratori
viru
surveil
system
broadcast
weekli
case
chest
radiograph
done
investig
physician
discret
order
rule
pneumonia
exclus
criteria
histori
antibiot
treatment
day
visit
exacerb
chronic
lung
diseas
within
month
activ
lesion
chest
paranas
sinu
radiograph
avail
immunocompromis
statu
confirm
altern
caus
cough
eg
drug
newli
start
angiotensinconvert
enzym
inhibitor
pneumonia
allerg
rhiniti
sinus
gastroesophag
reflux
stabl
chronic
lung
diseas
patient
exclud
multiplex
rtpcr
perform
use
detect
kit
solgent
daejeon
south
korea
use
viral
primer
panel
target
influenza
b
respiratori
syncyti
viru
parainfluenza
viru
coronaviru
human
metapneumoviru
hmpv
enteroviru
rhinoviru
human
bocaviru
adenoviru
rtpcr
perform
use
thermal
cycler
biorad
hercul
ca
usa
pcr
assay
detect
mycoplasma
pneumonia
chlamydophila
pneumonia
perform
previous
describ
primer
target
adhesin
gene
pneumonia
rrna
gene
c
pneumonia
legionella
pneumophila
primer
target
specif
region
within
rrna
gene
pcr
test
bordetella
pertussi
perform
describ
nelson
et
al
use
repeatedinsert
sequenc
primer
pcr
assay
virus
atyp
bacteria
perform
regardless
sputum
accept
file
categor
variabl
analyz
use
chisquar
test
fisher
exact
test
continu
variabl
analyz
use
student
ttest
mannwhitney
utest
pvalu
consid
statist
signific
analys
conduct
use
spss
statist
softwar
ibm
spss
statist
version
ibm
armonk
ny
usa
enrol
patient
primari
clinic
nonteach
commun
hospit
universityaffili
teach
hospit
mean
patient
age
year
men
tabl
accept
sputum
specimen
receiv
patient
mean
cough
durat
outpati
visit
shorter
accept
day
vs
unaccept
day
p
sputum
amount
larger
moder
larg
amount
accept
vs
unaccept
p
purul
sputum
common
among
patient
accept
sputum
sampl
patient
unaccept
sputum
sampl
accept
vs
unaccept
p
lower
respiratori
sign
wheez
crackl
rhonchi
stridor
common
accept
sputum
group
tabl
enrol
patient
accept
sputum
specimen
includ
analysi
etiolog
distribut
multiplex
pcr
test
virus
identifi
fig
commonli
rhinoviru
coronaviru
coinfect
viru
detect
patient
commonli
rhinoviru
plu
enteroviru
rhinoviru
plu
adenoviru
virus
identifi
significantli
fall
winter
vs
p
rhinoviru
show
peak
incid
fall
fig
pcr
test
atyp
pathogen
posit
patient
pneumonia
n
c
pneumonia
n
l
pneumophila
n
b
pertussi
n
overal
strain
typic
bacteria
cultur
patient
haemophilu
influenza
streptococcu
pneumonia
isol
frequent
coinfect
typic
bacteria
found
investig
patient
tabl
mix
infect
least
one
bacterium
typic
atyp
least
one
viru
demonstr
patient
accept
sputum
bacteriaonli
virusonli
infect
observ
patient
respect
organ
identifi
remain
patient
fig
patient
viral
infect
concurr
infect
least
one
bacteri
agent
rhinoviru
common
viru
mix
infect
bacteria
distribut
mix
infect
patient
accept
sputum
shown
tabl
overal
preval
viral
infect
similar
patient
without
chronic
lung
diseas
tabl
infect
caus
atyp
pathogen
especi
pneumonia
observ
less
frequent
chronic
lung
diseas
patient
wherea
infect
typic
bacteria
detect
commonli
patient
chronic
lung
diseas
vs
p
howev
incid
coinfect
ie
multipl
bacteri
agent
mix
infect
ie
bacterium
viru
differ
significantli
patient
without
chronic
lung
diseas
virus
overal
preval
higher
younger
patient
tabl
p
rhinoviru
preval
caus
infect
patient
show
trend
declin
preval
older
age
p
typic
bacteri
agent
trend
higher
preval
older
age
p
signific
differ
atyp
pathogen
preval
coinfect
mix
infect
differ
across
three
age
group
compar
clinic
characterist
accord
microorgan
group
tabl
bacteriaonli
group
significantli
older
mean
age
vs
year
p
includ
significantli
men
vs
p
virusonli
group
sore
throat
common
virusonli
group
bacteriaonli
group
vs
p
patient
mix
infect
show
intermedi
valu
bacteriaonli
virusonli
group
term
mean
age
sex
ratio
sore
throat
preval
best
knowledg
among
largest
prospect
multicent
studi
regard
microbiolog
acut
bronchiti
notabl
patient
acut
bronchiti
accept
sputum
evid
bacteri
infect
typic
atyp
higher
frequenc
viral
infect
also
distribut
infecti
etiolog
differ
age
presenc
underli
chronic
lung
diseas
final
mix
infect
common
patient
viral
infect
also
bacteri
infect
recent
placebocontrol
random
trial
antibiot
appear
provid
minim
benefit
treat
acut
bronchiti
therefor
often
assum
acut
bronchiti
primarili
viral
diseas
accordingli
previou
studi
usual
focus
viral
etiolog
includ
sputum
cultur
use
serolog
test
bacteria
may
underestim
bacteria
role
acut
bronchiti
creer
et
al
detect
bacteria
virus
acut
bronchiti
patient
respect
prompt
author
consid
bacteri
infect
rel
uncommon
howev
collect
sputum
specimen
bacteri
cultur
portion
patient
patient
submit
swab
nasal
aspir
viral
test
sputum
specimen
adequaci
discuss
contrast
collect
sputum
specimen
patient
viral
typic
bacteri
atyp
bacteri
infect
simultan
although
previou
studi
show
antibiot
littl
benefit
treat
acut
bronchiti
sever
factor
may
affect
result
first
patient
includ
studi
inhomogen
consider
proport
may
upper
respiratori
tract
infect
uri
appropri
evalu
antibiot
effect
fulli
differenti
group
bacteri
etiolog
second
use
term
bacteri
infect
lower
respiratori
tract
necessarili
impli
requir
antibiot
mani
infect
cure
without
antibiot
third
even
bacteri
infect
treat
use
antibiot
subject
symptom
postinfecti
cough
upperairway
cough
syndrom
might
persist
interestingli
random
control
trial
patient
uri
antibiot
clinic
benefici
subgroup
whose
nasopharyng
secret
contain
respiratori
bacteria
although
presenc
bacteri
agent
alway
indic
diseas
antibiot
treatment
might
benefici
subgroup
patient
bacteri
etiolog
creactiv
protein
procalcitonin
level
may
eventu
provid
object
marker
evalu
need
antibiot
treatment
recent
studi
use
term
lower
respiratori
tract
infect
lrti
condit
approxim
acut
bronchiti
lrti
character
acut
cough
least
one
lower
respiratori
tract
symptom
includ
purul
sputum
dyspnea
wheez
chest
discomfort
chest
pain
studi
attempt
limit
patient
enrol
patient
acut
bronchiti
howev
uri
patient
might
enrol
symptom
overlap
potenti
bia
consid
interpret
result
howev
cohort
patient
accept
sputum
could
consid
purer
group
acut
bronchiti
patient
patient
accept
sputum
sputum
product
auscultatori
abnorm
strongli
support
diagnosi
lrti
earlier
studi
viral
preval
rhinoviru
influenza
commonli
detect
importantli
studi
span
entir
year
limit
winter
influenza
season
enrol
patient
entir
year
fewer
enrol
winter
like
exclud
typic
symptom
influenza
winter
studi
common
bacteri
agent
h
influenza
follow
pneumonia
previou
studi
found
pneumonia
frequent
pathogen
other
found
h
influenza
frequent
howev
detect
pneumococc
antigen
sputum
urin
pcr
airway
secret
pneumonia
found
lrti
case
use
sputum
cultur
detect
typic
bacteria
incid
pneumonia
might
underestim
interestingli
pneumonia
isol
older
patient
twice
commonli
younger
patient
vs
year
vs
p
therefor
pneumococc
vaccin
may
benefici
prevent
acut
bronchiti
associ
pneumonia
older
patient
addit
studi
warrant
mix
infect
occur
patient
patient
previou
studi
lrti
nonimmunocompromis
adult
communityacquir
pneumonia
cap
typic
combin
viralbacteri
mix
infect
studi
rhinoviru
common
viru
mix
infect
sever
studi
suggest
rhinoviru
pathogen
lrti
unclear
whether
rhinoviru
trigger
secondari
bacteri
infect
also
viralbacteri
mix
infect
induc
sever
inflamm
diseas
individu
infect
cap
case
clinic
featur
outcom
studi
patient
mix
infect
acut
bronchiti
lrti
without
pneumonia
found
distinct
characterist
mix
infect
exclud
patient
chronic
lung
diseas
larg
proport
patient
evalu
cough
clinic
recent
review
mohan
et
al
detect
virus
via
pcr
rtpcr
patient
acut
exacerb
copd
rate
observ
copd
patient
studi
howev
none
copd
asthma
patient
posit
pneumonia
c
pneumonia
b
pertussi
despit
potenti
methodolog
problem
studi
use
pcr
also
found
copd
exacerb
associ
pneumonia
c
pneumonia
previou
multicent
studi
demonstr
absenc
b
pertussi
patient
chronic
lung
diseas
found
preval
rhinoviru
adenoviru
pneumonia
acut
bronchiti
higher
young
adult
observ
consist
prior
lrti
studi
convers
frequenc
typic
bacteria
higher
older
age
group
demonstr
studi
cap
result
suggest
antibiot
may
benefici
older
patient
acut
bronchiti
petersen
et
al
report
antibiot
substanti
reduc
pneumonia
risk
chest
infect
acut
bronchiti
particularli
elderli
patient
summari
bacteri
infect
identifi
etiolog
half
acut
bronchiti
patient
accept
sputum
infecti
etiolog
differ
age
presenc
underli
chronic
lung
diseas
mix
infect
bacteria
virus
common
futur
research
direct
identif
patient
group
like
benefit
antibiot
treatment
